Rabies vaccine
واکسن هاری
🦠 Antiinfectives For Systemic UseInactivated vaccine
Market / country: 🇺🇸 USA
Imovax Rabies (US)
🧮 Dose calculator
Rabies post-exposure prophylaxis (animal bite) · Regimen source: FDA Imovax Rabies · 2.2
- • Unvaccinated or immunosuppressed: days 0, 3, 7, 14 and 28, with rabies immune globulin on day 0. Previously vaccinated: days 0 and 3 only, no immune globulin. Away from the immune globulin site. FDA Imovax Rabies · 2.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⚠️ Pre-exposure: life-threatening systemic hypersensitivity to a component. No contraindication after exposure. FDA Imovax Rabies · 4
Formulations
- 1 mL dose after reconstitution — injection 🇺🇸 USA FDA Imovax Rabies · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Imovax Rabies · 8.1
“Risk Summary All pregnancies have a risk of birth defect, loss, or other adverse outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Imovax Rabies · 8.2
“Data are not available to assess the effects of IMOVAX RABIES on the breastfed infant or on milk production/excretion.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Imovax Rabies · 8.4
“Safety and efficacy have been established in all pediatric age groups [See Adverse Reactions (6.1) and Clinical Studies (14) ] .”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Imovax Rabies · 8.5
“Clinical studies of IMOVAX RABIES did not include sufficient numbers of participants aged 65 and over to determine whether they respond differently from younger participants [See Adverse Reactions (6.1) and Clinical Studies (14) ] .”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)BLA103931
- DailyMed (FDA label)FDA Imovax Rabies
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDJ07BG01
- Darooyab (Iran)Rabies-Vaccines
🇮🇷 Registered in Iran Darooyab · G-3505/Rabies-Vaccines
Dosage forms with Iranian generic codes, per Darooyab.
- 14051 · VACCINE-RABIES PCEC VIAL · ویال واکسن–هاری پسک
- 52107 · RABIES VACCINE INJECTION, POWDER, FOR SUSPENSION PARENTERAL 2.5 [iU] 1 mL · پودر برای تهیه سوسپانسیون تزریقی واکسن هاری ۲٫۵ واحد بینالمللی ۱ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Imovax Rabies · 3FDA Imovax Rabies · 2.2FDA Imovax Rabies · 2.1FDA Imovax Rabies · 4FDA Imovax Rabies · 8.1FDA Imovax Rabies · 8.2FDA Imovax Rabies · 8.4FDA Imovax Rabies · 8.5FDA Imovax Rabies · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3505/Rabies-Vaccines
- Clinical review⚠ Unverified